loading...
Life Science People recruits scientists, clinicians, and commercial talent exclusively for life sciences companies, pairing placement with recruitment infrastructure consulting and talent advisory.
ENTRY ANGLES
Specialist recruiting agency in fast-growing niche as entry point to build relationships and sector knowledge · Venture platform connecting investors and companies within a vertical · Brokering introductions and partnerships between incumbents and emerging players
VERTICALS
CAPABILITIES
Deep sector immersion and relationship building, Network effects management (connecting multiple stakeholder groups), Understanding investor thesis and partnership value creation
AND I THINK WE'LL GET THERE.
“We want to be the world's largest life science recruiter”
Life Science People is a specialist recruiting agency focused exclusively on the life sciences sector – biotech, pharma, medical devices, diagnostics, and medical technology research. Within that sector, they recruit across functions: scientists and clinicians, but also sales, operations, and technology roles including developers and AI specialists.
Beyond traditional contingency recruiting, the firm offers two additional service layers. One is recruitment infrastructure consulting: helping companies design hiring processes, document those processes, implement technical integrations with their HR platforms, and set up external candidate pipelines. The other is an embedded model, where Life Science People effectively acts as the client's in-house recruiting team – running full-cycle recruitment through to a final shortlist, with the company only needing to make the final call.
The embedded model is particularly suited to early-stage companies that need to hire aggressively but don't have the bandwidth or justification to build their own recruiting infrastructure yet.
After two and a half years of operation – during which more than 500 companies used their services and approximately 2,000 hires were completed – Life Science People has raised its first external round: £4M (approximately $5M USD).
A telling quote from a past interview with the founder: "We want to be the world's largest life science recruiter – and I think we'll get there."
This kind of ambition sounds routine until you consider the strategic logic behind it. The choice to specialize in one vertical rather than compete as a generalist agency is a bet on the economics of category leadership.
The founder puts it plainly from his own history: "My previous two recruiting companies each grew from zero to £100M in revenue – one took seven years, the next took five. Life Science People was on track to generate £8M in its first year. That's like a rocket compared to before."
The acceleration reflects a deliberate confluence of two decisions. Commit to a specific niche, and commit to a niche in a strong tailwind. The post-pandemic surge in pharma, biotech, and health technology investment created a wave of hiring demand that Life Science People caught early. Its year-one revenue outpaced comparable business types because the sector was expanding fast, not just because the recruiting was better.
The investment case for category leadership is also numerical. In most service markets, the second and third players are valued at 3–5x revenue. The clear category leader is valued at 10–15x. Choosing to be first in a niche rather than mid-tier in a large market compounds the return on every hour spent building the business.
The broader playbook here is "first mover in a fast-growing niche" – find a vertical that's expanding, commit to it fully, and accumulate the positioning advantage before the market matures. Life sciences is one example; the model applies wherever a sector is growing fast and lacks a dominant specialist firm.
What's underappreciated about Life Science People is how far beyond recruiting they've extended their positioning. They operate a venture platform connecting roughly 200 angel investors and venture funds focused on health and biotech. They broker introductions between companies – connecting traditional pharma firms with tech startups, or large incumbents with emerging players. Both activities generate additional revenue and, more importantly, give the team real-time visibility into which problems investors are excited about and which partnerships are creating value.
This suggests an underused tactic for founders who are clear on a niche but uncertain what product to build: start a specialist recruiting agency in that niche first. The model generates revenue from day one, forces deep immersion in the sector, and builds relationships with the founders, operators, and investors who will eventually become your customers, co-founders, or early employees. By the time you're ready to build a product, you're starting from a position of knowledge and trust rather than from cold outreach.
The actionable version: identify a fast-growing vertical where no clear specialist recruiting firm has yet established itself. Enter as a recruiter. Use that access to develop conviction about the most promising product opportunities. Launch from a position of relationships and domain fluency, not from a blank page.